Robert E Conway's Net Worth
$3.62 Million
Who is Robert E Conway?
Robert E Conway has an estimated net worth of $3.62 Million. This is based on reported shares across multiple companies, which include ARCA biopharma, Inc., PRA International, ALPINE IMMUNE SCIENCES, INC., and ARRAY BIOPHARMA INC.
SEC CIK
Robert E Conway's CIK is 0001184334
Past Insider Trading and Trends
2006 was Robert E Conway's most active year for acquiring shares with 7 total transactions. Robert E Conway's most active month to acquire stocks was the month of August. 2006 was Robert E Conway's most active year for disposing of shares, totalling 10 transactions. Robert E Conway's most active month to dispose stocks was the month of October. 2021 saw Robert E Conway paying a total of $464,565.00 for 79,650 shares, this is the most they've acquired in one year. In 2006 Robert E Conway cashed out on 375,000 shares for a total of $1,625,837.55, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARCA biopharma, Inc. (ABIO) Snapshot price: $1.6166
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| +25.00% | 10K |
$3.19 | $31,947.00 | 50K |
May 12
| |||
Form 4
| +33.33% | 10K |
$3.23 | $32,345.00 | 40K |
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
| +50.00% | 10K |
$4.16 | $41,630.00 | 30K |
Dec 18
| |||
Form 4
| +33.33% | 5K |
$4.28 | $21,399.50 | 20K |
Sep 25
| |||
Form 4
| +25.59% | 3.06K |
$4.66 | $14,240.65 | 15K |
Sep 22
| |||
Form 4
| +514.40% | 10K |
$4.77 | $47,660.00 | 11.94K |
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +40.00% | 10K |
$2.49 | $24,900.00 | 35K |
Jul 14
| |||
Form 4
|
∞
| 25K |
$2.59 | $64,750.00 | 25K |
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PRA International No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALPINE IMMUNE SCIENCES, INC. (ALPN) Snapshot price: $27.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4/A
| +42.86% | 15K |
$10.08 | $151,153.50 | 50K |
Sep 23
| |||
Form 4
| +42.86% | 15K |
$10.08 | $151,153.50 | 50K |
Sep 23
| |||
Form 4
| +40.00% | 10K |
$9.80 | $97,966.00 | 35K |
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +66.67% | 10K |
$8.03 | $80,300.00 | 25K |
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +33.33% | 15K |
$2.28 | $34,200.00 | 60K |
May 8
| |||
Form 4
| +12.50% | 5K |
$2.34 | $11,700.00 | 45K |
May 9
| |||
Form 4
| +100.00% | 20K |
$2.30 | $46,000.00 | 40K |
May 5
| |||
Form 4
| +100.00% | 10K |
$2.26 | $22,600.00 | 20K |
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
∞
| 10K |
$8.10 | $81,000.00 | 10K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARRAY BIOPHARMA INC No price found
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.93% | 57.19K |
—
|
—
| 633.39K |
Oct 4
| |||
Form 4
| +4.54% | 25K |
$2.17 | $54,250.00 | 576.2K |
Jun 17
| |||
Form 4
| +3.77% | 20K |
$2.86 | $57,200.00 | 551.2K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| +12.19% | 57.47K |
—
|
—
| 529K |
Oct 4
| |||
Form 4
| -1.26% | -7.00K |
—
|
—
| 549.35K |
Dec 23 - Mar 31
| |||
Form 4
| +25.73% | 103.43K |
$1.59 | -$186,085.32 | 505.35K |
Oct 8
| |||
Form 4
| +14.38% | 50.53K |
—
|
—
| 401.92K |
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4
| +14.85% | 45.25K |
$0.60 | $30,749.40 | 349.93K |
Apr 15 - Apr 16
| |||
Form 4
| +2.61% | 15K |
$0.60 | $12,000.00 | 588.75K |
Dec 27 - Apr 9
| |||
Form 4
| +3.58% | 10K |
$0.60 | $6,000.00 | 289.06K |
Dec 21
| |||
Form 4
| +3.72% | 10K |
$0.60 | $6,000.00 | 279.06K |
Nov 16
| |||
Form 4
| +10.28% | 25K |
$6.55 | -$580,000.00 | 268.24K |
Scheduled
|
Nov 14 - Nov 15
| ||
Form 4
| +25.87% | 50K |
$5.31 | -$910,837.55 | 243.24K |
Scheduled
|
Nov 2 - Nov 3
| ||
Form 4
| -2.51% | -6.00K |
—
|
—
| 233.07K |
Jul 25 - Aug 4
| |||
Form 4
| -3.76% | -8.00K |
—
|
—
| 204.5K |
Sep 2 - Jul 30
| |||
Form 4
| +7.63% | 15K |
$0.60 | $9,000.00 | 211.66K |
Aug 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||